HemoShear Therapeutics' Convertible Note Round

HemoShear Therapeutics raised a round of funding on May 22, 2017.

HemoShear Therapeutics discovers novel biological targets and advances drug programs to treat metabolic disorders with significant unmet patient need. Its proprietary drug discovery platform, REVEAL-T…

Articles about HemoShear Therapeutics' Convertible Note Round: